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TRIM32-dependent transcription in adult neural
progenitor cells regulates neuronal differentiation
A-L Hillje1,2,4, MAS Pavlou1,2,4, E Beckmann1,3,4, MMA Worlitzer1, L Bahnassawy1,2, L Lewejohann3, T Palm1 and JC Schwamborn*,1,2
In the adult mammalian brain, neural stem cells in the subventricular zone continuously generate new neurons for the olfactory
bulb. Cell fate commitment in these adult neural stem cells is regulated by cell fate-determining proteins. Here, we show that the
cell fate-determinant TRIM32 is upregulated during differentiation of adult neural stem cells into olfactory bulb neurons.
We further demonstrate that TRIM32 is necessary for the correct induction of neuronal differentiation in these cells. In the
absence of TRIM32, neuroblasts differentiate slower and show gene expression profiles that are characteristic of immature cells.
Interestingly, TRIM32 deficiency induces more neural progenitor cell proliferation and less cell death. Both effects accumulate in
an overproduction of adult-generated olfactory bulb neurons of TRIM32 knockout mice. These results highlight the function
of the cell fate-determinant TRIM32 for a balanced activity of the adult neurogenesis process.
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During embryonic and early postnatal periods of develop-
ment, the mammalian brain develops through precisely
coordinated processes of neural stem cell (NSC) proliferation,
fate specification and migration (reviewed in Gotz and
Huttner1). In the adult mammalian brain, neurogenesis is
restricted to the subventricular zone (SVZ) of the lateral
ventricles and the dentate gyrus of the hippocampus.2 In the
SVZ, the adult NSCs are glial fibrillary acid protein (GFAP)-
expressing astrocytes (type B cells). As a defining feature of
all stem cells, these adult NSCs have the ability to
simultaneously self-renew and generate more fate-committed
daughter cells. The progeny of type B cells are rapidly dividing
transient amplifying cells (type C cells). Type C cells give rise
to young neuroblasts (type A cells) that eventually will become
olfactory bulb (OB) neurons or callosal oligodendrocytes.3
Neuroblasts generated in the SVZ leave their place of birth
and migrate via chain migration along the rostral migratory
stream (RMS) towards the OB. After reaching the OB, they
populate different OB layers where they differentiate and
maturate into fully functional neurons.4 How the sequential
transition between these cell fates, which represent diverse
levels of differentiation, is ensured is largely unknown.
TRIM32 belongs to the family of TRIM-NHL proteins.
Previously, this protein family has been implicated in the
regulation of proliferation and differentiation of stem cells and
progenitor cells in Drosophila,5–8 Caenorhabditis elegans9
and the developing mammalian brain10,11 as well as the
mammalian skeletal muscle.12
Here, we analyzed the function of TRIM32 during neuro-
genesis in the adult mammalian brain. Our data indicate that
TRIM32 is upregulated during differentiation of SVZ-gener-
ated neuroblasts and that it is important for the induction of
neuronal differentiation of these cells. Finally, by analyzing
neurogenesis with TRIM32 gain-of-function and loss-of-
function approaches we show that TRIM32 indeed regulates
fate specification in adult NSCs. Interestingly, the TRIM32-
deficiency-induced overproduction of adult-generated OB
neurons is caused by a combined effect of increased
progenitor proliferation and less apoptosis in the OB. These
results highlight the function of the cell fate-determinant
TRIM32 for a balanced activity of the adult neurogenesis
process.
Results
In the adult mammalian brain, NSCs (type B cells) localized in
the SVZ give rise to fast-dividing transient amplifying cells
(type C cells). These differentiate into the more lineage-
restricted neuroblasts (type A cells). Neuroblastsmigrate from
the SVZ along the RMS towards the OB where they
differentiate into neurons and get integrated into the existing
network (Figure 1a).
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TRIM32 is expressed in neuroblasts and neurons. As
nothing is known about the function of TRIM32 during adult
neurogenesis, we investigated the expression of TRIM32 in
the adult mouse SVZ–OB system. For studying mRNA
expression levels of TRIM32 in neural progenitor cells, we
used adult mice expressing green fluorescent protein (GFP)
under the control of the promoter of the neural progenitor
marker Nestin. In these mice, newly generated neurons,
which are generated in the SVZ and migrate rostrally,
express GFP until they reach the OB.13 We isolated GFP-
positive neural progenitors from microdissected SVZ, prox-
imal part of the RMS (PRMS), distal part of the RMS (DRMS)
and OB from these mice via FACS analysis. The RNA was
isolated from these fractioned cells, and the TRIM32 mRNA
levels were investigated through reverse transcription-
quantitative PCR (RTq-PCR). We were able to detect
expression of TRIM32 in progenitors from all regions.
Additionally, the expression levels of TRIM32 mRNA were
comparable in neural progenitor cells from all investigated
regions (Figure 1b and Supplementary Figure S1a). In the
next steps, we made further use of these Nestin-GFP mice to
determine the expression of the TRIM32 protein via
immunofluorescence stainings. Adult NSCs (type B cells)
are characterized by the expression of the two markers
Nestin and GFAP. By using Nestin-GFP mice together with
immunostainings against GFAP and TRIM32, we were able
to show that the TRIM32 protein is virtually absent from type
B cells in the SVZ (Figure 1c). Specificity of the anti-TRIM32
antibody has been shown previously14 and is confirmed by
TRIM32 short hairpin RNA (shRNA) experiments (see
below). Additionally, staining of sections from wild-type
mouse brain with the type C cell marker Mash-1 showed
that also the majority of transient amplifying type C cells
were not positive for TRIM32 (Figure 1d, Supplementary
Table S1). Neuroblasts, which are already committed to the
neuronal cell fate, leave the SVZ in an immature state and
become more mature during their migration along the RMS
towards the OB. These neuroblasts are positive for the
Figure 1 TRIM32 mRNA is expressed throughout the SVZ–OB system, but TRIM32 protein is virtually absent from the majority of type B and C cells. (a) Schematic
drawing of the neuronal lineage: type B cells (stem cell astrocytes) in the SVZ give rise to type C cells (transient amplifying cells), which differentiate into type A cells
(neuroblasts). Type A cells further differentiate into mature neurons. (b) RT-qPCR measuring the relative TRIM32 mRNA expression levels within the different indicated adult
brain regions derived after micro-dissection and Nestin-GFP-based FACS analysis (N¼ 3; mean±S.E.M.; t-test). (c and d) Immunostainings of mouse brain sections labeled
with the indicated antibodies. Images were taken in the SVZ. Bars¼ 20mm, for high magnifications 5 mm (c) and 10mm (d)
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microtubule-associated protein doublecortin (DCX).
Co-stainings for DCX and TRIM32 revealed that neuroblasts
express TRIM32 (Figure 2). This expression of TRIM32
strongly increases when neuroblasts mature and reach the
OB (Figure 2b and c). The TRIM32 expression further
increases when the cells leave the RMS, populate the OB
and start to express the neuronal marker neuronal nuclei
(NeuN; Figure 3). Interestingly, early in the proximal RMS the
expression of TRIM32 is mainly cytoplasmic, while it
becomes more nuclear in neuroblasts at the distal RMS
and OB. In NeuN-positive neurons, TRIM32 is strongly
expressed and exclusively localized in the nucleus of the
cells. Among the NeuN-positive cells in the granular cell
layer (GCL), 95% express also TRIM32, while 70% of the
NeuN-positive neurons in the glomerular cell layer (GL)
show a strong expression of nuclear TRIM32 (Figure 3,
Supplementary Figures S1n and o). Together, these expres-
sion data suggest that TRIM32 mRNA levels are present
through the entire SVZ–RMS–OB system without presenting
any significant changes. However, the TRIM32 protein
becomes upregulated during neuronal cell fate commitment.
Most probably, post-transcriptional events are responsible
for a lack of significant translation of the TRIM32 mRNA in
type B and C cells.
In good agreement with the protein expression pattern,
the majority of mitotically active Ki67-positive cells, as
well as dividing PH-3-positive cells, are negative for
TRIM32 (Supplementary Figures S1b–e). Additionally, astro-
cytes and oligodendrocytes show only very low levels of
TRIM32 immunostaining (Supplementary Figures S1f–h,
Supplementary Table S1).
Next we analyzed whether TRIM32 is indeed expressed in
adult-generated neurons. Therefore, we stained mouse
brain sections 8 days after injection of the nucleotide analog
5-ethynyl-2’-deoxyuridine (EdU) for EdU and TRIM32
(Figures 3b and d). EdU-positive cells were detectable all
along the SVZ–OB. Especially in the middle and DRMS,
EdU/TRIM32 double-positive cells were detectable
(Supplementary Figures S1i–m.). This fraction of EdU/
TRIM32 double-positive cells increased strongly within the
OB (Figure 3d and Supplementary Figures S1i–m). In the
GCL, 80% of the EdU-positive cells express TRIM32, while in
the GL TRIM32 was detectable in 50% of the EdU-labeled
cells (Figure 3d).
Finally, we aimed to analyze the TRIM32-expressing
neuronal subtypes in more detail. We found that TRIM32 is
not only expressed in NeuN-positive neurons of the GCL and
GL (Supplementary Figures S1n and o) but that it is also
expressed in the Calbindin-positive neurons of the GL
(Supplementary Figure S1p). Additionally, TRIM32 is
expressed in GABAergic, glutamatergic and dopaminergic
neurons in theOB (Supplementary FiguresS1q–s). Interestingly,
the expression of TRIM32 in neurons and neuroblasts seems
to be conserved from mice to primates (Marmoset and
Macaque monkeys) (Supplementary Figures S1t and u).
This expression analysis revealed that in cells with high
potential for self-renewal and proliferation (like type B and C
cells) TRIM32 is only very weakly expressed. However, during
neuronal cell fate specification the levels of TRIM32 increase
strongly.
Absence of TRIM32 leads to an overproduction of
adult-generated OB neurons. As TRIM32 is upregulated
during the critical period of differentiation of neuroblasts into
neurons in the adult SVZ–OB system, we analyzed the
activity of neurogenesis in TRIM32-deficient mice. Wild-type
and TRIM32 knockout mice were injected with bromodeox-
yuridine (BrdU) on 3 consecutive days, and brains were fixed
14 days after the last injection (Figure 4a).
By comparing wild-type with TRIM32 knockout mice, we
found significantly more BrdUþ cells in the GCL of these
knockout mice (Figures 4b–d, Supplementary Table S2).
Interestingly, although significantly more new cells (BrdU
positive) were generated for the OB of TRIM32 knockout
mice, the neuronal differentiation of these cells was not
defective. Both in wild-type mice as well as in TRIM32
knockoutmice, nearly all BrdU-positive cells differentiated into
neurons within 14 days (Figure 4d, Supplementary Table S2).
Additionally, the amount and differentiation status of BrdUþ
cells in the GL was unchanged in TRIM32 knockout mice
(Supplementary Figure S2, Supplementary Table S2). Finally,
differentiation into glia cells is unchanged in the absence of
TRIM32 (data not shown). An overproduction of new neurons
for the OB could be caused by the generation of more new
cells or a decreased rate in cell death. To first address the
latter, apoptotic profiles in the GCL of TRIM32 knockout and
WT mice were compared using terminal deoxynucleotidyl-
transferase-mediated dUTP nick end labeling (TUNEL)
staining as well as cleaved caspase-3 (Casp3) staining
(Figure 4e). Indeed, we found significantly less apoptotic cells
in the GCL of TRIM32 knockout mice (Figures 4e and f and
Supplementary Table S2). We conclude that in the absence of
TRIM32 in the adult SVZ–OB system more newly generated
neurons populate the GCL. The overproduction is caused at
least partially by a reduced apoptosis rate in TRIM32 knockout
mice (analysis of proliferation: see below). However, within
the long time period of 14 days from the birth of these cells to
analysis of their fate their ability to undergo neuronal
differentiation was not impaired. Clearly, with this assay we
would be unable to detect a cell autonomous delay of
differentiation at early stages of differentiation that is
potentially caused by the absence of TRIM32. Therefore, in
the next step we conducted cell autonomous knockdown of
TRIM32 and did the analysis 8 days after this knockdown.
TRIM32 is regulating neuronal differentiation of adult
NSCs. TRIM32 knockout mice have more adult-generated
cells in their OB (Figure 4). Fourteen days after birth,
neuronal differentiation seems not to be affected in those
adult-generated cells. However, there might be an impair-
ment of differentiation at early stages that might be rescued
at 14 days after birth and therefore not detected with the
assay conducted above. Furthermore, because this is a
complete knockout it is impossible to study cell autonomous
effects. In order to conduct a detailed analysis of TRIM32
function during fate specification, we overexpressed or
knocked down this gene in individual adult NSCs of the
SVZ and analyzed manipulated cells at 8 days after infection.
Therefore, we stereotactically injected retroviruses for over-
expression (TRIM32 with IRES-EGFP (internal ribosome
entry site-enhanced GFP)), knockdown (two independent
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Figure 2 Expression of TRIM32 increases in neuroblasts through the RMS into the OB. (a) Schematic representation of the SVZ–RMS–OB system is shown.
(b) Immunostainings of mouse brain sections, taken from regions indicated in panel (a), labeled with the indicated antibodies. Bars¼ 20mm, high magnification 10mm.
(c) Quantification of the percentage of neuroblasts expressing TRIM32 (mean±S.E.M., t-test, nZ735 cells, N¼ 3 mice). The expression of TRIM32 increases from immature
cells in the SVZ to mature neurons in the OB
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TRIM32 shRNA constructs, EGFP expression from a
separate promoter) and control (scrambled shRNA and
EGFP expression) into the adult SVZ (Figure 5). Function-
ality of the shRNA constructs was proven by western blotting
and immunofluorescence stainings in vitro and in vivo
(Supplementary Figures S3a–d). Furthermore, these results
confirm the specificity of our anti-TRIM32 antibodies. The
fate of transduced cells was analyzed 8 days after injection.
At this time point, the majority of the control cells (expressing
only EGFP) were localized in the DRMS (Figure 5b).
In contrast, a knockdown of TRIM32 led to a significant
increase in the amount of cells that remained in the SVZ,
while overexpression of TRIM32 resulted in the accumulation
of transduced cells in the PRMS and middle RMS
(Figure 5b).
To investigate the effect of TRIM32 on proliferation in
transduced cells, brain sections were stained with the cell
cycle marker Ki67. A knockdown of TRIM32 increased the
amount of proliferative cells strongly, whereas TRIM32
overexpression resulted in a significant reduction of Ki67-
positive cells. This effect was detectable irrespectively of the
localization of the transduced cells (Figure 5c) and was not
limited to cells within the SVZ (Figures 5d–g). Strikingly, upon
knockdown of TRIM32 we were even able to detect some
mitotic cells (showing characteristically condensed chromatin)
within the distal RMS (Supplementary Figure S3d); this is an
observation that we never observed for EGFP-expressing
control cells.
To investigate neuronal fate commitment, we used the
marker neuronal class III b-tubulin (TuJ1). Overexpression of
TRIM32 led to a small but significant increase of TuJ1-positive
cells. In contrast, a knockdown of TRIM32 strongly reduced
the amount of transduced TuJ1-positive cells (Supplementary
Figure S4). The effects observed for TuJ1 are probably not so
pronounced, because this marker not only labels postmitotic
neurons but is also expressed in neuroblasts. However, when
we analyzed the TuJ1 stainings after TRIM32 knockdown, we
sometimes found clusters of TuJ1 negative, transduced round
cells within the RMS that were reminiscent of type C-cell
cluster that are usually found in the SVZ (Supplementary
Figure S5).
During their differentiation, neuroblasts start to express
NeuN and become postmitotic neurons. Therefore, we used
NeuN to finally evaluate the effect of TRIM32 on terminal
Figure 3 TRIM32 is strongly expressed in adult-generated neurons of the OB. (a and b) Immunostainings of mouse brain sections, taken in the OB, labeled with the
indicated antibodies. Bars¼ 20mm, for high magnifications 10 mm. (c and d) Diagrams showing the percentage of cells in the GL and GCL of the OB that are double positive
for NeuN and TRIM32 (c) and EdU and TRIM32 (d) (mean±S.E.M., nZ3 mice). These results indicate that TRIM32 is expressed in adult-generated neurons of the OB
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Figure 4 TRIM32 knockout mice show an increase in the number of newborn neurons and decreased rates of apoptosis. (a) Schematic drawing of the experimental
paradigm. For 3 days, mice received a daily injection of BrdU; 14 days later, the brains were fixed and analyzed. (b) Immunostainings of sections from the OB-GCL of wild-type
and TRIM32 knockout mice labeled with the indicated antibodies. Bars¼ 50mm, for high magnifications 15mm. (c–d) Diagrams showing the relative amount of BrdU-positive
cells in the OB-GCL (c) and the amount of cells that are double positive for BrdU and NeuN in the OB-GCL (d). All quantifications were conducted in wild-type and knockout
mice (mean±S.E.M., NZ4 mice; t-test, * Po0.05). (e) TUNEL stainings of sections from wild-type and TRIM32 knockout mice OB-GCL. Bars¼ 15mm. (f and g) Diagrams
showing the relative amount of TUNELþ (f) and Casp3þ (g) cells in the OB-GCL. (Median±S.E.M., NZ4 mice, Mann–Whitney U Test *Po0.05). These results show that
in the absence of TRIM32 in the adult OB-GCL more cells are generated and that these cells eventually undergo neuronal differentiation
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Figure 5 Knockdown of TRIM32 induces proliferation in neural progenitor cells. (a) Schematic representation depicting the migration process of the neural progenitor cells
from the SVZ to the OB. Viruses for expression of a scrambled shRNA sequence (control), TRIM32-shRNA or overexpression of TRIM32 were injected in the SVZ. All
constructs express GFP under an independent promoter. Eight days after injection, brain sections were analyzed. (b) Quantification of the position of GFP-positive cells in
injected brains (mean±S.E.M., NZ700; N48 mice, Mann–Whitney U test, *Po0.05; **Po0.01). (c) Ki67 was used as a proliferation marker. A quantification of
GFP-positive cells that are also positive for Ki67, summarizing all brain regions, is shown (mean±S.E.M., nZ700; N48 mice, Mann–Whitney U test, *Po0.05; **Po0.01).
(d–f) Immunostainings of mouse brain sections after injection of viruses for GFP, TRIM32-shRNA or TRIM32, taken from the SVZ and labeled with the indicated
antibodies. Bars¼ 15mm. (g) Quantification of GFP-positive cells in the SVZ, which are also positive for Ki67 (mean±S.E.M., nZ500; NZ8 mice, Mann–Whitney U test,
*Po0.05; **Po0.01). The results presented here indicate that TRIM32 regulates proliferation of neural progenitor cells
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neuronal differentiation. Strikingly, a cell autonomous knock-
down of TRIM32 by shRNA 8 days after infection resulted in a
strong reduction of NeuN-positive neurons, whereas its
overexpression facilitated neuronal differentiation (Figure 6).
Altogether, these data indicate that TRIM32 is necessary for
the correct induction of neuronal differentiation of adult neural
progenitor cells.
TRIM32 regulates the gene expression profile of
neuroblasts. To analyze the molecular changes that occur
upon loss of TRIM32, we performed a whole transcriptomic
microarray analysis on mRNAs extracted from fresh tissue
dissections of the PRMS and DRMS from wild-type and
TRIM32 knockout mice (red and brown circles, Figure 7a).
For wild-type and TRIM32 knockout mice, each indicated
region was profiled in triplicate. Via a correspondence
analysis (CoA), a high degree of similarity between analogous
samples was demonstrated (Figure 7b). Additionally, this
analysis illustrated that the four triplicate groups strongly
differed in terms of anatomic localization (PRMS versus
DRMS) and of genotype (wild-type versus TRIM32 knockout).
To specifically isolate genes with expression profiles
differing between wild-type and TRIM32 knockout samples
during the neuronal maturation, that is, when cells migrate and
differentiate from PRMS to DRMS, we used the following
filtering steps (Figure 7c): In the first step, genes that were two
times upregulated or downregulated in wild-type or in TRIM32
KO animals were isolated. Through superimposing both
groups (1008 transcripts regulated in wild-type and 1420
transcripts regulated in the TRIM32 knockout), we were able
to distinguish between those genes that are regulated
according to the anatomic localization (744 transcripts) and
those genes that are exclusively regulated because of loss of
TRIM32 (676 transcripts). In order to determine the function of
these 676 TRIM32 regulated genes, we used a Gene
Ontology (GO) analysis approach. Interestingly, this analysis
significantly related the TRIM32-regulated genes to terms,
including ‘neuron differentiation’, ‘neuron development’,
‘morphogenesis’ and multiple terms associated with neuronal
maturation, such as ‘transmission of nerve impulse’ and
‘neuron projection development’ (Figure 7 and Supplementary
Figure S6a). In the next step, we focused the analysis on
mechanisms that are known to be involved in stem cell fate
decisions. By using the gene expression data, we investigated
how the expression levels of key genes being involved in stem
cell fate decisions change during neuronal maturation
(comparing PRMS with DRMS) in the absence and presence
of TRIM32. Indeed, a series of genes that are differentially
expressed when comparing wild-type and TRIM32 knockout
animals were detectable (Figure 7e). Together, this gene
expression analysis supports the notion that TRIM32 is an
important regulator of neuronal differentiation and that
loss of TRIM32 severely impairs and decelerates neuronal
commitment.
To finally address whether the loss of TRIM32 indeed
impairs neuronal differentiation, we made use of the fact that
neuronal differentiation is accompanied by cell cycle exit.
Additionally, the GO analysis (Figure 7d), as well as
the analysis of selected deregulated genes (Figure 7e,
Supplementary Table S3), strongly suggests that the cell
cycle might be a valid readout for TRIM32 activity. Indeed,
when we analyzed the amount of Ki67-positive cells in the OB
of wild-type and TRIM32 knockout mice, we detected a strong
increase for cell cycle active (Ki67 positive) cells in the
absence of TRIM32 (Figures 7f and g, Supplementary Figure
S6b and Supplementary Table S4). The same effect was
detectable from SVZ throughout the RMS (Figure 7h).
Strikingly, this increase in the amount of Ki67-positive cells
correlates with the continuous increase of TRIM32 expression
from SVZ to OB (compare with Figure 2c). Additionally, these
results indicate that the increased amount of adult-generated
cells in the OB of TRIM32 knockout mice is not only the result
of decreased apoptosis but also that increased proliferation
has a role.
Thus this analysis suggests that TRIM32 is important for
neuronal differentiation and in the absence of TRIM32
numerous genes associated to this process are deregulated
leading to increasing amounts of cells remaining in the cell
cycle.
Discussion
Although mechanisms regulating the generation and specifi-
cation of neurons are well described, only little is known about
factors that initiate exit from an immature neuronal precursor
state and induce terminal neuronal differentiation during adult
mammalian neurogenesis. Data presented in this study
indicate that the expression of the cell fate determinant
TRIM32 increases gradually from young neuroblasts to
postmitotic neurons in the SVZ–OB system. Cell autonomous
TRIM32 gain-of-function and loss-of-function approaches
revealed that TRIM32 is able to induce cell cycle exit of
mitotic progenitor cells and is necessary for accurate timing of
terminal neuronal differentiation in adult NSCs. Finally,
investigating the molecular mechanism, microarray data
indicate that the differentiation-associated translocation of
TRIM32 into the nucleus has extensive consequences for the
transcriptome of differentiating neuroblasts.
The expression of the TRIM32 protein increases
continuously from low levels in just specified neuroblasts in
the SVZ to high levels in neuroblasts at the DRMS where
neuroblasts differentiate into postmitotic neurons of the OB.
These increasing levels of TRIM32 suggest that neuroblasts
maturate during their migration from the SVZ to the OB. What
Figure 6 Correct induction of neuronal differentiation depends on the presence of TRIM32. Viruses for expression of a scrambled shRNA sequence (control), TRIM32-
shRNA or overexpression of TRIM32 were injected in the SVZ. All constructs express GFP under an independent promoter. Eight days after injection, brain sections were
analyzed. (a) NeuN was used as a neuronal differentiation marker. A quantification of GFP-positive cells that are also positive for NeuN, summarizing all brain regions is shown
(mean±S.E.M., nZ500; nZ8 mice, Mann–Whitney U test, *Po0.05; **Po0.01). (b–d) Immunostainings of mouse brain sections, taken from the OB and labeled with the
indicated antibodies. Boxed areas are shown in higher magnification. Red arrows indicate transduced cells that are positive for NeuN. Bars¼ 15mm for the first three columns,
10mm for the fourth and fifth columns. (e) Quantification of GFP-positive cells in the OB, which are also positive for NeuN (mean±S.E.M., nZ500; NZ8 mice,
Mann–Whitney U test, *Po0.05; **Po0.01). These results indicate that TRIM32 is necessary for the correct induction of neuronal differentiation of neuroblasts
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Figure 7 Molecular profiling demonstrates deregulated neuronal differentiation in TRIM32 knockout mice. (a) Schematic representation reflecting the migration and
maturation of neural progenitor cells with regions of isolated tissue samples indicated by red (PRMS) and brown (DRMS) circles. (b) CoA performed on the 5000 transcripts
with the highest S.D. throughout the series of 12 microarrays analyzed. (c) Schematic illustration of the expression data filtering process. For wild-type (blue) and TRIM32
knockout (red) mice, gene expression levels were compared between the PRMS and the DRMS. Genes with twofold regulation (dark blue or dark red triangles) were isolated
for further data processing. In all, 1008 transcripts were at least twofold regulated when comparing PRMS and DRMS in wild-type mice, whereas 1420 transcripts were twofold
regulated in TRIM32 knockout animals. From these genes, 744 transcripts were simultaneously designated as regulated in wild-type and TRIM32 knockout mice and thus are
varying independently from the genotype. A total of 676 transcripts were exclusively regulated in TRIM32 knockout mice and are therefore specifically associated with loss of
TRIM32. (d) GO term analysis of the 676 transcripts exclusively associated with loss of TRIM32. The bar diagram represents the log(1/P-value) (Fisher’s exact test). The entire
list of GO terms is shown in Supplementary Figure S6. (e) Bar diagram of the expression changes of genes implicated in NSC fate-regulating mechanisms. Black and grey bars
represent the log of the ratio calculated from the gene expression intensity within the DRMS and within the PRMS of wild-type and of TRIM32 knockout mice.
(f) Immunostainings of brain sections (wild-type and TRIM32 knockout), taken from the OB and labeled with the indicated antibodies. Boxed areas are shown in higher
magnification. Bars¼ 25mm, for high magnifications 10 mm. (g) Bar diagram of the relative amount of Ki67þ cells in the OB of wild-type and TRIM32 knockout mice
(mean±S.E.M., NZ4 mice, Mann–Whitney U test, *Po0.05). (h) Bar diagram of the relative amount of Ki67þ cells in the SVZ and RMS of wild-type and TRIM32 knockout
mice (mean±S.E.M., NZ4 mice, Mann–Whitney U test, *Po0.05)
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might be the contribution of TRIM32 to this differentiation/
maturation process? Our data indicate that neuroblast
maturation is not only associated with increasing levels of
TRIM32 but also with a translocation of TRIM32 into the
nucleus. Previously, we have shown that TRIM32 on the one
hand binds to Argonaute proteins and activates micro-
RNAs,10 while on the other hand it induces degradation of
c-Myc after translocation into the nucleus.11 Therefore, it is
tempting to speculate that cytoplasmic TRIM32 in neuroblasts
of the PRMS initiates differentiation/maturation via micro-
RNA activation, while the differentiation process is finalized in
neuroblasts of the distal RMS and young neurons of the OB
through TRIM32 translocation to the nucleus. In line with this,
it has been recently shown that during neuronal differentiation
processes TRIM32 is involved in retinoic acid receptor-
mediated transcription.14,15 Furthermore, the involvement of
retinoic acid signaling in adult neurogenesis has been
described intensively.16–18 Additionally, human TRIM32
(HT2A) has been reported to undergo nuclear translocation
and to interact with the activation domain of lentiviral Tat
proteins.19 Interestingly, a similar nuclear translocation to
induce differentiation has been shown for other tumor-
suppressor proteins, such as PTEN.20 In good agreement
with the hypothesis that nuclear translocation of TRIM32
induces terminal neuronal differentiation, a huge fraction of
the genes with functions in cell cycle regulation, neuronal
differentiation, maturation and related processes are deregu-
lated in the absence of TRIM32. However, because eventually
neuronal differentiation is also occurring in the absence of
TRIM32, its function seems to be transient, mainly to induce
differentiation and thereby to regulate the exact timing of
neuronal specification.
A remaining question is how these functions on the
molecular level actually affect cellular features like prolifera-
tion, differentiation and survival. With a BrdU-incorporation
protocol designed to evaluate the amount of newborn
neurons, knockout mice lacking TRIM32 had nearly 90%
more new adult-generated granule neurons than their WT
counterparts. As TRIM32 is absent from the majority of type B
and C cells and its expression is upregulated in neuroblasts
(type A cells) along the RMS together with the results that we
obtained by acute overexpression or knockdown of TRIM32,
it seems likely that this increased amount of newly generated
cells is the result of increased proliferation of neuroblasts
along the RMS. Strikingly, this inverse correlation between
TRIM32 expression and proliferation becomes obvious in
TRIM32 knockout mice. In regions where TRIM32 is usually
only expressed at low levels (e.g., the SVZ) TRIM32 knockout
mice only show a moderate increase in proliferative cells.
However, in regions with increasing TRIM32 levels (RMS to
the OB), TRIM32 knockout mice show comparable increasing
levels of proliferation (compare with Figures 2c, 7g and h).
Additionally, to this effect on proliferation we found reduced
levels of apoptosis in theOB of TRIM32 knockout mice. This is
in good agreement with the recently reported pro-apoptotic
function of TRIM32.21 Interestingly, other reports describe
TRIM32 as an inhibitor of apoptosis.22 Seemingly the pro- or
anti-apoptotic function of TRIM32 depends on the cell type
and probably even on other circumstances, such as stress
level or differentiation status.
Adult neurogenesis holds great regenerative potential for
restoring affected brain regions of patients suffering from
neurodegenerative diseases. Experimental manipulation of
TRIM32 in transplanted or endogenous NSCs could be an
interesting new therapeutic approach for cell replacement
therapies.
Materials and Methods
Material and plasmids. For immunolabeling, the following antibodies were
used: anti-TRIM32 (Gramsch Laboratories, Schwabhausen, Germany), anti-Nestin
(BD Biosciences, Franklin Lakes, NJ, USA), anti-GFAP, anti-GFP (Abcam,
Cambridge, UK), anti-polysialylated-neural cell adhesion molecule (Millipore,
Billerica, MA, USA), anti-DCX (Millipore), anti-Mash-1 (BD Biosciences), anti-NeuN
(Millipore), anti-Ki67 (BD Pharmingen, San Diego, CA, USA and Vector Labs,
Burlingame, CA, USA), glutathione S-transferase p (anti-GST p; Abcam), anti-
gamma-amino butyric acid (anti-GABA; Abcam), anti-vesicular glutamate
transporter 2 (Abcam), anti-Tuj1 (Covance, Princeton, NJ, USA), anti-tyrosin
hydroxylase (Chemicon Millipore, Temecula, CA, USA), anti-BrdU (AbDSerotec,
Kidlington, UK) and anti-Casp3 (Asp175, Cell Signaling Technology, Danvers,
MA, USA). DNA was stained with Hoechst (Abcam). For virus production, the
retrovirus packaging vector PCL-ECO23 and the following transfer plasmids were
used: pMX-GFP23 for control experiments, the coding sequence of TRIM32 was
cloned into the pMSCV-CITE-EGFP-PGK-Puro vector (kindly provided by Dr. Manuel
Grez, Georg Speyer Haus, Biomedical Research Institute, Frankfurt, Germany), and
retroviral TRIM32 shRNA constructs were obtained commercially (Genescript,
Hong Kong).
Cell culture, transfection and western blotting. N2A cells were
grown in DMEM supplemented with 10% heat-inactivated FCS, 2 mM
L-Glutamine, 100 U/ml Penicillin and 100mg/ml Streptomycin. The cells were
transfected using Turbofect (Fermentas, Burlington, ON, Canada) according to the
manufacturer’s instructions and were lysed 48 h after transfection with lysis buffer
1 (2% Triton X-100, Complete protease inhibitor cocktail (Roche, Basel,
Switzerland), 20 mM NaF and 20 mM Na3VO4 in phosphate-buffered saline
(PBS)) for 30 min at 4 1C. The cell lysates were centrifuged for 30 min at 13 000
r.p.m. at 4 1C, the supernatant was mixed with sample buffer, boiled at 95 1C for
5 min and used for western blotting for further analysis. To ensure loading of equal
amounts of protein for SDS-PAGE and western blotting, the total concentration of
proteins was determined with a BCA protein assay kit (Thermo Scientific,
Waltham, MA, USA) according to the manufacture’s instruction. Furthermore,
equal amounts of blotted protein were verified by Ponceau S (Sigma, St Louis,
MO, USA) staining on the membrane. Analysis of the western blots was done
using the Image J software (National Institute of Mental Health; http://
rsb.info.nih.gov/ij).
RTq-PCR. For isolation of neural progenitors, adult mice expressing GFP under
the control of the promoter of the neural progenitor marker Nestin were used.
Newly generated neurons, which are generated in the SVZ and migrate rostrally,
express GFP until they reach the OB.13 Tissue from the SVZ, pRMS, dRMS and
the OB of four 5–month-old Nestin-GFP mice was dissected under a binocular and
collected in cold DMEM. For dissociation of the tissue into a single-cell
suspension, cells were incubated with papain at 37 1C and flushed through a
pipette tip followed by a cell strainer (BD Biosciences). Sorting was done using a
FACS Aria II cell sorter (Becton Dickinson, Franklin Lakes, NJ, USA).
Total RNA was extracted from Nestin-GFP-positive cells by the miRNAeasy kit
(Qiagen, Venlo, Netherlands) following the manufacturer’s recommendations.
TRIM32 expression levels were evaluated by the KAPA SYBR Fast Master Mix
(Peqlab, Erlangen, Germany) following the manufacturer’s recommendations.
TRIM32-related intensity levels were evaluated upon normalization with GAPDH
levels.
Used primers are listed below:
TRIM32-F: 50-GCATCCAGGAAGAGCTAG-30;
TRIM32-R: 50-CTCTACCACTTGACTGTTG-30;
GAPDH-F: 50-ACAATGAATACGGCTACAG-30; and
GAPDH-R: 50-GGTCCAGGGTTTCTTACT-30.
Immunohistochemistry of free-floating sections. All animals used
in this study were maintained and treated according to the approved protocols and
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in accordance with the institutional and national guidelines and regulations. Mice
were deeply anaesthetized by intraperitoneal injection of 0.017 ml of 2.5% Avertin
(100% stock solution: 10 g 2, 2, 2-Tribromoethanolin 10 ml tert-Amylalcohol) per
gram of body weight and killed by perfusion. Brains were fixed overnight at 4 1C in
4% paraformaldehyde in PBS. Later, sections of 40 mm were prepared using a
vibratome (Leica, Wetzlar, Germany) and blocked for at least 1 h in TBS (0.1 M
Tris,150 mM NaCl, pH 7.4) containing 0.5% Triton X 100, 0.1% Na-Azide, 0.1%
Na-Citrate, and 5% normal goat serum. Immunostainings were performed by
incubation of the sections with primary antibodies diluted in the blocking solution
for 48 h at 4 1C on a shaker, followed by incubation with the secondary antibody
diluted in the blocking solution for 2 h at room temperature. Finally, sections were
mounted in AquaMount (DAKO, Glostrup, Denmark). Images were collected by
confocal microscopy using the ZEN software (Zeiss, Jena, Germany); image
analysis was performed with the ZEN software (Zeiss), Adobe Photoshop
(San Jose, CA, USA), Image J software and Imaris software (Zurich, Switzerland).
Immunohistochemistry of free-floating sections (Callithrix
jacchus andMacaca). Marmoset (Callithrix jacchus) and macaque (Macaca)
monkeys were raised in the institutional breeding facility of the Centre of
Reproductive Medicine and Andrology. Breeding, maintenance and experimental
procedures were performed in accordance with the German Federal law on the
Care and Use of laboratory animals. The animals were deeply sedated using
ketamine and killed by exsanguination. Brains from adult marmoset and macaque
monkeys were obtained from local colonies at the Institute of Reproductive
Medicine, University of Mu¨nster, Mu¨nster, Germany. Those brains were processed
for immunohistochemistry as described above for mouse brains.
TUNEL and Casp3 staining. TUNEL staining was used to detect DNA
fragmentation in situ and performed with the In Situ Cell Death Detection Kit, TMR
red (Roche, Cat. No. 12156792910) according to the manufacturer’s instructions.
In brief, 40-mm brain sections of mouse brains were obtained as described above
and blocked for 1 h at room temperature in TBS containing 0.5% Triton X-100,
0.1% Na-Azide, 0.1% Na-Citrate and 5% normal goat serum. Sections were
washed in PBS twice for 5 min each in PBS and incubated with the TUNEL
labeling solution. Therefore, two brain sections were simultaneously incubated with
250ml of TUNEL labeling solution in one well of a 24-well plate for 1 h at 37 1C
covered with aluminium foil. Sections were once washed with PBS containing
Hoechst for 10 min at room temperature to stain nuclei. Before mounting sections
in AquaMount (DAKO), they were once washed in PBS for 10 min at room
temperature. TUNEL-positive (TUNELþ ) cells were counted and by normalizing
the quantified values to the area of the granule cell layer of the according OB
values were expressed as densities (cells/mm2).
Apoptotic cells were additionally labeled with a Casp3 antibody (Asp175, rabbit)
from Cell Signaling Technology. Casp3þ cells were counted and by normalizing
the quantified values to the area of the granule cell layer of the according OB
values were expressed as densities (cells/mm2). P-values are calculated by the
Mann–Whitney U test.
EdU and BrdU injections. Cell proliferation in vivo was analyzed by using
the Click-iT EdU Kit (Invitrogen, Carlsbad, CA, USA) according to the
manufacturer’s instructions or injection of BrdU followed by antibody staining
with an anti-BrdU antibody (AbDSerotec). For both the procedures, animals were
injected with 50 mg/kg EdU or BrdU on 3 consecutive days and killed after the
indicated time. For BrdU staining, sections were incubated with 2 M HCl in PBST
(PBSþ 0.3% Triton) for 25 min at 37 1C for denaturation of the DNA, neutralized
with 0.1 M sodium tetraborate (pH 8.5) for 7 min at room temperature and stained
with an anti-BrdU antibody.
Virus production and stereotactic injections. For virus production,
TLA-HEK293T (Open Biosystems, Huntsville, AL, USA) cells were transfected with
the retroviral packaging vector PCL-ECO and the according transfer plasmid using
Turbofect (Fermentas) following the manufacturer’s instructions. The culture media
were collected 24, 48 and 56 h after transfection, pooled and cleared from
remaining cells by centrifuging 10 min at 1200 r.p.m. at 4 1C. To concentrate the
virus, the supernatant was centrifuged at 20 000 r.p.m. at 4 1C for 90 min, and the
pellet was resolved in DMEM without any additives.
For transduction of neural progenitors in vivo, mice were deeply anaesthetized by
intraperitoneal injection of 0.017 ml of 2.5% Avertin (100% stock solution: 10 g 2, 2,
2-Tribromoethanolin 10 ml tert-Amylalcohol) per gram of body weight and waited
until the mice did not respond to pinching with tweezers. In all, 2.5ml of retrovirus
were manually injected (0.5ml per minute) in the SVZ (stereotactic coordinates:
APþ 0.6, MLþ / 0.84, DV—2.5) of each hemisphere of the brain using a
stereotactic frame (David Kopf Instruments, Tujunga, CA, USA). The injection of the
virus vectors was executed as described previously.24 Mice were killed 8 days
after surgery by perfusion, and the dissected brains were used for
immunohistochemistry.
Microarray analysis. For comparing gene expression patterns of the PRMS
and DRMS, freshly dissected brains were cut with a vibratome (Leica, Wetzlar,
Germany) in 100mm sections, and the corresponding brain regions were isolated
using a binocular microscope and shock frozen immediately after isolation. For the
PRMS and the DRMS of respectively wild-type and Trim32 KO mice, the tissue
extracted from three individual mice was pooled. RNA was isolated using the
RNeasy Kit (Qiagen) according to the manufacturer’s instructions. mRNA quantity
and purity were determined by using a NanoDrop ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE, USA). Additional quality check was
performed by the Agilent Bioanalyzer (Agilent, Santa Clara, CA, USA). Gene
expression profiles were generated at the Genomics Division of the Integrated
Functional Genomics (Core Unit of the Interdisciplinary Center for Clinical
Research (IZKF) at the Medical Faculty of the University of Mu¨nster) using the
MouseGene 1.0ST arrays according to manufacturer’s recommendations
(Affymetrix, Santa Clara, CA, USA). Digitalized images were processed using
the Affymetrix Expression Console (PLIER summarization method, Sketch—
quantile normalization method and PM-GCBG background analysis method) to
obtain intensity files.
Microarray data analysis. For the CoA, we used the appropriate software
implemented in the Tigr MEV platform.25 Data analysis were performed on the
5000 transcripts with the highest S.D. The number for neighbors for KNN
imputation was equal to 10. GO analysis was performed using the appropriate
software implemented in the Database for Annotation, Visualization and
Integrated Discovery (DAVID).26 P-values are calculated by the Fisher’s
exact test.
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